Ibuprofen reduces plasma nitrite/nitrate levels in a rabbit model of endotoxin-induced shock

Neuroendocrinology Letters

Volumn 26, Issue 4, 2005, Pages 407-412

  Akbulut, Handan ^a   Celik, Ilhami ^a   Ayar, Ahmet ^a   Vural, Pervin ^b   Canbaz, Mukaddes ^b  

^a FIRAT UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Blood pressure; Endotoxic shock; Ibuprofen; Nitric oxide; Nitrite nitrate; Rabbit

Indexed keywords

ESCHERICHIA COLI ENDOTOXIN; IBUPROFEN; NITRATE; NITRIC OXIDE; NITRITE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL PRESSURE; ARTICLE; BLOOD LEVEL; BLOOD PRESSURE; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG MECHANISM; DRUG RESPONSE; NONHUMAN; RABBIT; SEPTIC SHOCK;

EID: 27244439241     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Abel FL, Beck RR. Canine peripheral vascular response to endotoxin shock at a constant cardiac output. Circ Shock 1988; 25:267-74.
2. Abraham E, Marshall JC. Sepsis and mediator directed therapy, rethinking the target populations. Mol Med Today 1999; 5:56-58.
3. Aeberhard EE, Henderson SA, Arabolos NS, Griscavage JM, Castro FE, Barrett CT, Ignarro LJ. Nonsteroidal anti-inflammatory drugs inhibit expression of the inducible nitric oxide synthase gene. Biochem Biophys Res Commun 1995; 208:1053-1059.
4. Bernard GR, Wheeler AP, Russell JA, Schein R, Summer WR, Steinberg KP, Fulkerson WJ, Wright PE, Christman BW, Dupont WD, Higgins SB, Swindell BB. The effects of ibuprofen on the physiology and survival of patients with sepsis. N Engl J Med 1997; 336:912-918.
5. Bredt DS. Endogenous nitric oxide synthesis, biological functions and pathophysiology. Free Radic Res 1999; 31:577-596.
6. Burgner D, Rockett K, Kwiatowski D. Nitric oxide and infectious diseases. Arch Dis Child 1999; 81:185-188.
7. Cobb J, Danner R. Nitric oxide and septic shock. JAMA 1996; 275: 1192-1196.
8. Cobb JP. Nitric oxide synthase inhibition as therapy for sepsis, a decade of promise. Surg Infect 2001; 2:93-100.
9. Coran AG, Drongowski RA, Paik JJ, Remick DG. Ibuprofen intervention in canine septic shock, reduction of pathophysiology without decreased cytokines. J Surg Res 1992; 53:272-279.
10. Evans T, Carpenter A, Kinderman H, Cohen J. Evidence of increased nitric oxide production in patients with the sepsis syndrome. Circ Shock 1993; 41:77-81.
11. Grisham MB, Johnson GG, Lancaster JR Jr. Quantitation of nitrate and nitrite in extracellular fluids. Methods Enzymol 1996; 268:237-46.
12. Heidemann SM, Ofenstein JP, Sarnaik AP. Ibuprofen attenuates cardiopulmonary dysfunction by modifying vascular tone in endotoxemia. Prostaglandins Leukot Essent Fatty Acids 1999; 60:181-185.
13. Howe LM. Novel agents in the therapy of endotoxic shock. Expert Opin Investig Drugs 2000; 9:1363-1372.
14. Jacobi J. Pathophysiology of sepsis. Am J Health Syst Pharm 2002, 59:3-8.
15. Kleinbongard P, Dejam A, Lauer T, Rassaf T, Schindler A, Picker O, Scheeren T, Godecke A, Schrader J, Schulz R, Heusch G, Schaub GA, Bryan NS, Feelisch M, Kelm M. Plasma nitrite reflects constitutive nitric oxide synthase activity in mammals. Free Radic Biol Med 2003; 35:790-796.
16. Llorens S, Nava E. Cardiovascular diseases and the nitric oxide pathway. Curr Vasc Pharmacol 2003; 1:335-346.
17. Mitaka C, Hirata Y, Yokoyama K, Nagura T, Tsunoda Y, Amaha K. Beneficial effect of carboxy-PTIO on hemodynamic and blood gas changes in septic shock dogs. Crit Care Med 1997; 1:45-50.
18. Parillo JE. Pathogenetic mechanisms of septic shock. N Engl J Med 1993; 328:1471-1485.
19. Pinsky MR. Cardiovascular response in canine endotoxic shock, effect of ibuprofen pretreatment. Circ Shock 1992; 37:323-332.
20. Stoclet JC, Martinez MC, Ohlmann P, Chasserot S, Schott C, Kleschyov AL, Schneider F, Andriantsitohaina R. Induction of nitric oxide synthase and dual effects of nitric oxide and cyclooxygenase products in regulation of arterial contraction in human septic shock. Circulation 1999; 100:107-112.
21. Stratman NC, Carter BC, Sethy VH. Ibuprofen, effect on inducible nitric oxide synthase. Molecular Brain Research 1997; 50:107-112.
22. Stuehr DJ. Mammalian nitric oxide synthases. Biochim Biophys Acta 1999; 1411:217-30.
23. Symenoides S, Balk RA. Nitric oxide in the pathogenesis of sepsis. Infect Dis Clin North Am 1999; 13:449-463.
24. Thiemermann C, Vane J. Inhibition of nitric oxide synthesis reduces the hypotension induced by bacterial lipopolysaccharides in the rat in vivo. Eur J Pharmacol 1999; 182:591-595.
25. Tracey WR, Tse J, Carter G. Lipopolysaccharide-induced changes in plasma nitrite and nitrate concentrations in rats and mice, pharmacological evaluation of nitric oxide synthase inhibitors. J Pharmacol Exp Ther 1995; 272:1011-5.
26. Tuteja N, Chandra M, Tuteja R, Misra MK. Nitric Oxide as a Unique Bioactive Signaling Messenger in Physiology and Pathophysiology. J Biomed Biotechnol 2004; 4:227-237.
27. Vandivier RW, Eidsath A, Banks SM, Preas HL, Leighton SB, Godin PJ, Suffredini AF, Danner RL. Down-regulation of nitric oxide production by ibuprofen in human volunteers. J Pharmacol Exp Ther 1999; 289:1398-1403.
28. Wever RM, Luscher TF, Cosentino F, Rabelink TJ. Atherosclerosis and the two faces of endothelial nitric oxide synthase. Circulation 1998; 97:108-112.
29. Wolkow PP. Involvement and dual effects of nitric oxide in septic shock. Inflamm Res 1998; 47:152-66.
30. Yamanaka S, Iwao H, Yukimura T, Kim S, Miura K. Effect of the platelet-activating factor antagonist, TCV-309, and the cyclooxygenase inhibitor, ibuprofen, on the haemodynamic changes in canine experimental endotoxic shock. Br J Pharmacol 1993; 110:1501-7.